-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Cellular and Cytokine Modulation of the Tumour Microenvironment

Program: Scientific Program
Session: JOINT Session - The Lymphoma Microenvironment and Its Impact on Therapy
Hematology Disease Topics & Pathways:
Research, Lymphomas, Diseases, Therapies, Lymphoid Malignancies
Sunday, December 11, 2022, 9:30 AM-11:05 AM

Saad S. Kenderian, MD

Division of Hematology, Mayo Clinic, Rochester, MN

Disclosures: Kenderian: LEAH Labs: Current holder of stock options in a privately-held company, Research Funding; MustangBio: Patents & Royalties; Viracta/Sunesis: Research Funding; Tolero: Research Funding; Lentigen: Research Funding; Morphosys: Research Funding; Humanigen: Consultancy, Membership on an entity's Board of Directors or advisory committees, Patents & Royalties: CART cell therapy , Research Funding, Speakers Bureau; Life Engine: Current holder of stock options in a privately-held company; Juno/BMS: Consultancy, Research Funding, Speakers Bureau; Kite/Gilead: Consultancy, Research Funding, Speakers Bureau; Novartis: Consultancy, Patents & Royalties: CART cell therapy , Research Funding, Speakers Bureau; Mettaforge: Patents & Royalties.

See more of: JOINT Session - The Lymphoma Microenvironment and Its Impact on Therapy
See more of: Scientific Program
<< Previous Presentation | Next Presentation